HSBC Mutual Fund Crosses 5% Stake in Thyrocare Technologies

HSBC Mutual Fund has disclosed a substantial acquisition of shares in Thyrocare Technologies Limited, crossing the 5% threshold as per SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The fund's holding, including persons acting in concert, now stands at 6.63% post-acquisition. This disclosure is a regulatory requirement triggered by acquiring shares or voting rights that aggregate to 5% or more of the target company's total shareholding. The acquisition involved purchasing 49,99,751 shares, increasing the fund's total stake from 4.75% to 6.63%. The shares were acquired through open market purchases, with the last acquisition date noted as August 13, 2026.